I−III−VI2 semiconductor nanocrystals have been applied to a host of energy conversion devices with great success. Large scale implementation of device concepts based on these materials has, however, been somewhat stymied by the strong role of defects in determining the optoelectronic characteristics of these materials. Here we present a perspective view of the role of electronic structure and defects on the physical properties, particularly the spectroscopy, of this family of materials. Applications of these materials are further discussed in this context.
We
describe the electronic structure and spectroscopic properties
of CuAl
x
Fe1–x
S2 nanocrystals and their core/shell structures.
The as-synthesized CuAl
x
Fe1–x
S2 core exhibits a tetragonal chalcopyrite
structure. The core material exhibits tunable band gap that spans
the entire visible to near-infrared spectrum, from 3.48 to 0.53 eV.
This tunability is achieved by varying the mole fraction of aluminum
and iron from 1:0 to 0:1. The band gap variation with composition
deviates from Vegard’s law and corresponds to a bowing coefficient
of 1.59 eV. Our observations are interpreted using density functional
theoretical calculations. In particular, we find that the significant
bowing is well accounted for through significant localization of the
Fe electronic states. Most significantly, CuAl
x
Fe1–x
S2 shows
photoluminescence upon making a shell of zinc sulfide, which is tunable
from 400 to 1400 nm (3.1 to 0.89 eV). CuAl
x
Fe1–x
S2/ZnS are until
date the only visible-infrared tunable nanocrystal fluorophore composed
entirely of earth abundant elements with atomic numbers 30 and lower.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.